We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PKO:GPWPKO Bank Polski SA Analysis

Data as of 2026-03-10 - not real-time

$25.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Park‑Ohio Holdings trades at $25, well below its 20‑day simple moving average of $26.69 but still above the 50‑day SMA of $24.26, indicating a short‑term price pullback within a broader uptrend. The 30‑day volatility of 48% and a beta of 1.19 point to a stock that moves sharply with the market, raising short‑term risk. Technical momentum is mixed: the RSI sits at 45.6 (neutral) while the MACD histogram is negative and the signal line is labeled bearish. Nevertheless, volume is increasing and the trend direction is flagged bullish, supporting the case for a potential rebound toward the $29.5 resistance. Fundamentally, the company appears cheap, with a trailing P/E of 12.2 versus an industry average of 29.5 and a price‑to‑book below 1. The dividend yield of 2% and a modest payout ratio of 24% suggest current income is sustainable. However, the balance sheet is strained, with a debt‑to‑equity ratio of 175% and a max drawdown of 32%, which limits financial flexibility.
Analyst consensus, albeit from a single source, rates the stock as a strong‑buy with a mean target price of $37, implying roughly 48% upside from today. Forward earnings per share are projected to rise to $3.50, supporting a forward P/E of 7.1 and reinforcing the value narrative. The company’s diversified geographic footprint across North America, Europe and Asia mitigates regional concentration risk. While margins are thin (gross margin 17% and operating margin 5.5%), the low price‑to‑sales multiple of 0.23 adds a margin of safety. The extreme‑greed sentiment index (78.6) reflects strong market optimism, but the high leverage and volatility warrant cautious positioning. Overall, the stock offers an attractive entry point for value‑oriented investors willing to accept elevated risk. Investors should monitor debt reduction progress and cash‑flow generation as key catalysts for sustained upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support at $23.32 with bearish MACD
  • Increasing volume suggests buying interest
  • High volatility and beta increase short‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation metrics (P/E 12.2 vs industry 29.5)
  • Target price of $37 indicating ~48% upside
  • Sustainable dividend yield of 2% with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified geographic exposure reduces regional risk
  • Potential debt deleveraging improves balance‑sheet strength
  • Long‑term value upside supported by low price‑to‑sales and price‑to‑book ratios

Key Metrics & Analysis

Financial Health

Revenue Growth1.70%
Profit Margin1.49%
P/E Ratio12.2
ROE5.83%
ROA3.98%
Debt/Equity175.10
P/B Ratio0.9
Op. Cash Flow$41.3M
Free Cash Flow$4.5M
Industry P/E29.5

Technical Analysis

TrendBullish
RSI45.6
Support$23.32
Resistance$29.50
MA 20$26.69
MA 50$24.26
MA 200$20.74
MACDBearish
VolumeIncreasing
Fear & Greed Index78.61

Valuation

Target Price$37.00
Upside/Downside48.00%
GradeUndervalued
TypeValue
Dividend Yield2.00%

Risk Assessment

Beta1.19
Volatility48.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.